(
139
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Rethinking hereditary angioedema: What role can the first oral plasma kallikrein inhibitor play?
-
Exploring new horizons: The future of Hereditary Angioedema treatment
-
Focus on TAKHZYRO and real-world evidence: Why it matters for your patients with hereditary angioedema (HAE)
-
Hereditary angioedema (HAE): no patients left behind
-
Path to improving patient care in hereditary angioedema (HAE): what are the treatment goals and how can they be achieved?
-
The Evolving Evidence for the Long-Term, Prophylactic Treatment of Hereditary Angioedema Patients with Subcutaneous C1-INH
Show more Sponsored Symposia (4)Show Less-
-
Breakthroughs in mangement of urticaria and angioedema
-
Emerging treatments for angioedema
-
Flash Talks on food allergy, urticaria and angioedema
-
Flash Talks on urticaria and angioedema
-
Flash talks on angioedema
-
Hereditary angioedema: Current Situation and Future Perspectives
-
Urticaria and angioedema from bench to bedside
-
Durable reduction in hereditary angioedema (HAE) attack rates with berotralstat over 24 months: results from the phase 3 apeX-2 study
-
Flash Talks on hereditary angioedema
Show more Event Resources (7)Show Less-
-
Classification of Angioedema
-
Diagnosis of Angioedema
-
Differential Diagnosis of Angioedema
-
Introduction to Recurrent Angioedema – State of the Art and Future Directions
-
Pathogenesis of Mast Cell Driven and Bradykinin Mediated Angioedema
-
Risk Factors, Triggers and Potential Biomarkers of Angioedema
-
Tips & Tricks and Tools for Angioedema Management in Routine Clinical Practice
Show more Courses (5)Show Less-
Website
Collapse
-
A CASE REPORT OF RECURRENT LIP SWELLING IN A TEENAGE GIRL (clinical manifestation of hereditary alpha tryptasemia or not?)
-
A Novel Mutation of MYOF in Hereditary Angioedema: the First Two Case Reports in Asia and Analysis of Clinical Characteristics
-
A Physician-based Brazilian Registry for Hereditary Angioedema: insights from the first 508 Patients
-
A Physician-based Brazilian Registry for Hereditary Angioedema: insights from the first 508 Patients
-
A first structured diagnostic approach to identify underlying diseases of patients with acquired angioedema
-
A predictive model to differenciate chronic histaminergic angiodema and chronic spontaneous urticaria with angioedema
-
A predictive model to differenciate chronic histaminergic angiodema and chronic spontaneous urticaria with angioedema
-
Aging and hereditary angioedema: use of new long-term prophylactic therapies in the geriatric population
-
An Incomplete Acquired Angioedema In a 84-Year-Old Patient: Case Report
-
Angioedema due to acquired C1-inhibitor deficiency and lymphoid hemopathies
-
Angioedema due to acquired C1-inhibitor deficiency associated to monoclonal gammopathies of undetermined significance – Characteristics of a French national cohort
-
Angioedema in childhood: with or without urticaria
-
Angioedema in childhood: with or without urticaria
-
Barzolvolimab Significantly Improves Angioedema in Patients with Chronic Spontaneous Urticaria (CSU): Results from a Phase 2 Trial
-
Basal serum tryptase levels identify hereditary α-tryptasemia but are poor predictors of clonal mast cell disease in Hymenoptera venom allergy
-
Burden of Disease and Health-Related Quality of Life Impairment in Adult Patients With Hereditary Angioedema: Results From a Multinational Survey
-
CRISPR-based gene editing of KLKB1 resulted in long-term plasma kallikrein protein reduction and decreased attack rate in patients with hereditary angioedema: Updated results from a phase 1 study
-
Case report of a patient with C1-inhibitor acquired angioedema and prostate cancer treated with Lanadelumab relayed by Berotralstat
-
Clinical Characterization of a Group of Patients with Suspected Hereditary alpha-Tryptasemia
-
Clinical and laboratory features of patients with non-hereditary angioedema – a preliminary report of 37 cases
-
Comparison of Component Resolved Diagnosis (CRD) with skin prick test in respiratory allergy [36 cases] and Significance of CRD in Anaphylaxis [8 cases] & Chronic Urticaria with/ without Angioedema [16 cases]
-
Donidalorsen for the treatment of hereditary angioedema: Results from a phase 3, randomised, placebo-controlled trial
-
Flash talks on Angioedema
-
Garadacimab improves quality of life in patients with hereditary angioedema: Results from the Phase 3 open-label extension study
-
Gene Sequencing of Angioedema with Normal C1-INH in Israel
-
Genetic Studies in Angioedema
-
Global research productivity, participation, collaboration and focus in hereditary angioedema: A systematic bibliometric review
-
Hereditary Angioedema: Perspectives and Contrasts from the East
-
Hereditary Angioedema: Shifting Paradigms and Seeking a Cure
-
Hereditary alpha-tryptasemia and mastocytosis
-
Hereditary α-tryptasemia is associated with increased risk for drug-induced anaphylaxis
-
Identifying KIT D816V Mutation in Patients With Evidence of Systemic Mast Cell Activation (MCA) and Enriched for Hereditary Alpha-tryptasemia (HaT): Results From the PROSPECTOR Clinical Trial
-
Idiopathic angioedema due to acquired C1-inhibitor deficiency: a multicenter French cohort study of 34 patients
-
Inflammatory and kallikrein-kinin serum profiling of acute ACE-inhibitor angioedema
-
Is hereditary alpha-tryptasemia truly a risk factor for anaphylaxis?
-
Isolated and recurrent eyelid angioedema in an 8-year-old girl
-
Long-term Real-Life Effectiveness and Tolerability of Lanadelumab in Hereditary Angioedema: The Bulgarian Experience
-
Long-term safety of donidalorsen for the treatment of hereditary angioedema: Results from the phase 3 open-label extension OASISplus study
-
Managing Skin Allergies: Urticaria, Dermatitis, and Angioedema
-
Mast cell clonality, hereditary alpha-tryptasemia and anaphylaxis
-
Nitial Experience of Long-Term Prophylaxis with Lanadelumab for Hereditary Angioedema in China: a Clinical Observation
-
Omalizumab as a diagnostic and therapeutic trial for recurrent idiopathic angioedema
-
Oral Sebetralstat for On-demand Treatment of Hereditary Angioedema: Phase 3 KONFIDENT Trial Results
-
Pregnancy in Hereditary Angioedema: A Single Centre Experience
-
Preimplantation genetic testing in hereditary angioedema: prevention outperforms treatment
-
Rare cause of angioedema
-
Recurrent Uvular Angioedema After Intranasal Cocaine Use
-
Recurrent angioedema with the mutation in the Myoferlin gene. Clinical observations
-
Sebetralstat as Oral On-demand Treatment for Hereditary Angioedema: Interim Analysis of Demographics and Attack Characteristics from the Open-label KONFIDENT-S Trial
-
Self-reported treatment preferences of patients switching from prior prophylactic therapies to donidalorsen for the treatment of hereditary angioedema: Results from the phase 3 OASISplus study
-
A Phase 3 Open-Label Trial-In-Progress Evaluating Garadacimab For Prophylactic Treatment Of Pediatric Patients (Aged 2–11 Years) With Hereditary Angioedema
-
A sensitive and specific assay to characterize plasma kallikrein activity in plasma from hereditary angioedema (HAE) patients
-
Adverse Health Outcomes and Patient and Physician Perspectives of Attenuated Androgen Use in Hereditary Angioedema
-
Analysis of prodromal symptoms and need for short-term prophylaxis in hereditary angioedema patients under long-term prophylaxis
-
Anxiety Associated with On-Demand Treatment for Hereditary Angioedema Attacks
-
Attack-free Rates and Attack Characteristics in Patients with Hereditary Angioedema Receiving Non-androgen Long-term Prophylaxis
-
Being attack-free is associated with improved quality of life for patients with hereditary angioedema treated with garadacimab: Post hoc analysis from the pivotal Phase 3 (VANGUARD) study
-
BioCryst – Reimagining hereditary angioedema (HAE) care – is it time to define the new ‘normal’ for patients with HAE?
-
Breakthroughs in management of Hereditary Angioedema
-
Burden Of Hereditary Angioedema and Impact on Quality Of Life: Final Data From a Multinational Patient Survey
-
C1 inhibitor deficiency: a long road from the diagnosis of possible hereditary angioedema to the diagnosis of splenic marginal zone lymphoma
-
Characteristics of Nailfold Videocapillaroscopy in Hereditary Angioedema due to C1 Inhibitor Deficiency
-
Characteristics of Nailfold Videocapillaroscopy in Hereditary Angioedema due to C1 Inhibitor Deficiency
-
Clinical Impact of Long-Term Prophylaxis De-escalation with Lanadelumab in Hereditary Angioedema Type I and II
-
Clinical profile and management of pediatric hereditary angioedema in resource constrained settings: our experience from a single centre in North India
-
Clinical profile and management of pediatric hereditary angioedema in resource constrained settings: our experience from a single centre in North India
-
Comorbidities in hereditary angioedema patients in Canada: a quantitative survey study
-
Complement activation during erythema marginatum in patients with hereditary angioedema
-
Complement activation during erythema marginatum in patients with hereditary angioedema
-
Delayed On-demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers
-
Difficult to control hereditary angioedema during pregngancy
-
Effectiveness and safety of berotralstat in patients with hereditary angioedema with normal C1-inhibitor: A European case series
-
Efficacy and Safety of Oral Deucrictibant, a Potent Bradykinin B2 Receptor Antagonist, in Prophylaxis of Hereditary Angioedema Attacks: Results of CHAPTER-1 Phase 2 Trial
-
Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks: RAPIDe-3 Phase 3 Trial Design
-
Efficacy of lanadelumab on attack frequency and AE-QoL in Serbian patients with hereditary angioedema
-
Evaluation of Anxiety, Depression, and Death Anxieties in Patients Diagnosed with Hereditary Angioedema
-
Evolution of health-related quality of life and disease control during the first year of Lanadelumab treatment in Romanian patients with Hereditary Angioedema due to C1-inhibitor deficiency
-
Exploring the Relationship Between Airway Attacks and Patient-Reported Outcomes in Hereditary Angioedema
-
F12 c.983C>A gene variant is the predominant cause of hereditary angioedema with normal C1 inhibitor among Peruvian patients
-
Flash talks on Hereditary Angioedema
-
Genital Attacks in Hereditary Angioedema And Their Effects On Sexual Life
-
Health-related quality of life in hereditary angioedema patients using subcutaneous plasma derived C1 inhibitor therapy in Canada
-
Healthcare Provider Burden associated with the treatment of attacks in patients with hereditary angioedema in Latin America: A Pilot Study
-
Hereditary Angioedema (HAE) Patients Answer: Why Do Attacks Go Untreated?
-
Hereditary Angioedema Attack Diary Determination of the Effect of Mobile Application on Patients’ Quality of Life and Treatment Compliance Level
-
Hereditary Angioedema Type I in a 57-Year-Old Woman
-
Hereditary Angioedema in A Portuguese Paediatric Population
-
Hereditary angioedema and severe chronic urticaria, what the odds?
-
Hereditary angioedema caregiver burden. Data from the 2020 Canadian national survey
-
Hereditary angioedema with normal C1-Inhibitor: A series of 41 genetically characterized patients from Northern Portugal
-
Hereditary angioedema with normal C1-inhibitor level or Melkerson-Rosenthal syndrome?- response to the treatment: A case report
-
Impact of hereditary angioedema on dental care: from a study of 112 French patients
-
Insights into Hereditary Angioedema management
-
Interoceptive sensibility and body appreciation in patients affected by Hereditary Angioedema
-
Laryngeal Edema-Related Mortality in Hereditary Angioedema Patients: Insights from Verbal Autopsy Findings Obtained from Relatives
-
Long-term prophylaxis with first line therapies in patients with hereditary angioedema with C1 inhibitor deficiency, real-life experience
-
Online Education Yields Significant Gains in Physicians’ Knowledge of the Latest Data with Emerging Therapies for Hereditary Angioedema
-
Patients with hereditary angioedema in Belarus: data from the National registry of primary immunodeficiency disorders
-
Pregnancy, birth and postpartum follow-up of a Factor 12 Hereditary Angioedema patient with Familial Mediterranean Fever
-
Prevalence of Sleep Disorders in Patients with Hereditary Angioedema
-
Prophylactic Treatment with Oral Deucrictibant Improves Health-Related Quality of Life of Patients with Hereditary Angioedema
-
Prospective monitoring of clinical outcomes and laboratory markers of hereditary angioedema in patients on long-term prophylaxis with lanadelumab: One-year follow-up
-
Rationale and Design of the ALPHA-SOLAR Clinical Trial of STAR-0215 for the Treatment of Hereditary Angioedema (HAE)
-
Real-World Effectiveness and Safety of Lanadelumab for Hereditary Angioedema Attack Prophylaxis: A 3-Year Interim Analysis of the ENABLE Study
-
Results related to the implementation of a transdisciplinary care model in patients diagnosed with hereditary angioedema
-
Retrospective evaluation of the prevalence of autoimmunity in patients with hereditary angioedema
-
The Determinants of Acute Attack Development in Hereditary Angioedema Patients Undergoing Dental Interventions
-
The importance of individualizing in the choice of prophylaxis for hereditary angioedema
-
Under-representation and -reporting of race in global hereditary angioedema trials: A hidden yet alarming source of disparities
-
Understanding treatment switching patterns and continuation rates for patients with hereditary angioedema receiving lanadelumab: analysis of real-world data
-
Using data from the National Health Registries to estimate the burden and medication usage in Hereditary Angioedema in Colombia
-
Real-life features of hereditary angioedema attacks: first results from the registry supported by ITACA (Italian network for hereditary and acquired angioedema)
-
Migraine-like headache and quality of life in hereditary angioedema due to C1-inhibitor deficiency: first evidence from the Italian Network for Hereditary and Acquired Angioedema (ITACA)
-
Prediction of a hereditary angioedema attack in patients with recurrent angioedema: awareness at a glance with the hereditary angioedema prediction score (HAEps)
-
Turkish National Hereditary Angioedema and Acquired Angioedema Registry, Established to Encourage Standardizing the Care and Management of the Disease. HAE/AAE-TR National Hereditary and Acquired Angioedema Registry Group
Show more Sessions (113)Show Less-